combining anti-her2 agents with immunotherapy for her2 mbc
Published 4 years ago • 1.2K plays • Length 6:06Download video MP4
Download video MP3
Similar videos
-
1:06
immunotherapy combination in her2-positive breast cancer
-
1:37
dr. bhave on promising anti-her2 agents in her2 breast cancer
-
5:46
treating her2 mbc: immunotherapy and tkis
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
1:33
dr. rimawi on the clinical need for immunotherapy in her2-positive breast cancer
-
0:22
copy of dr. davis on immunotherapy in her2-positive gastric/gej cancer
-
0:34
her2-targeted therapies
-
0:58
enhertu therapy: a powerful new cancer treatment
-
6:09
emerging agents for her2 mbc: targeted therapeutics
-
9:30
1 1 = 3. combined use of anti-her2 agents in the neoadjuvant setting
-
49:25
optimizing therapy in her2 disease with dr. hope s. rugo
-
1:54
dr. khong on endocrine combinations in er /her2- breast cancer
-
0:45
dr. davis on immunotherapy in her2-positive gastric/gej cancer
-
53:19
her2 positive breast cancer: what's new in treatment and research at mbc patient forum 2019
-
1:28
dr. tripathy on immunotherapy potential in her2-positive breast cancer
-
6:54
key clinical trials investigating immunotherapy in her2 and hr breast cancer
-
1:53
dr. pegram on pertuzumab combination for her2-positive breast cancer
-
30:10
2022 ku post san antonio review | metastatic her2 positive breast cancer: novel treatment approaches
-
47:29
optimizing therapy in her2 disease with dr. reshma mahtani